EUVIMEDEUVIMED entdecken
Crossref

Graft-versus-host disease prophylaxis shapes T cell biology and immune reconstitution after hematopoietic cell transplant

Susan DeWolf iD, Steven J Siegel, Joseph Schmalz, Wael Saber iD, Alexandre Albanese iD, Jiayi Dong iD, Michael J Martens iD, Brent Logan iD, Lorenzo Iovino iD, Kayleigh Ingersoll-Ohmdahl, Nicholas Winn, Edward Chen iD und 47 weitere

Science Translational Medicine · 2026

DOI: 10.1126/scitranslmed.aef7406 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Translational Medicine, 2026. Verfasst von Susan DeWolf und 58 weiteren Autor:innen. Beteiligte Einrichtung: Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Hauptthemen laut MEDLINE: Graft vs Host Disease, Hematopoietic Stem Cell Transplantation, T-Lymphocytes, Immune Reconstitution. Die Arbeit nennt 75 Literaturangaben. Gefördert von: National Institutes of Health, DKMS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Successful hematopoietic cell transplant requires immunosuppression to prevent graft-versus-host disease (GVHD), a lethal, T cell–mediated complication. The phase 3 BMT CTN 1703 trial demonstrated superior GVHD-free/relapse-free survival for posttransplant cyclophosphamide (PT-Cy)–based GVHD prophylaxis versus tacrolimus/methotrexate (Tac/MTX), but the T cell biology underpinning these outcomes remains unknown. To determine this, 324 patients were coenrolled onto BMT CTN 1801 to investigate the distinct T cell immune reconstitution pathways of these regimens, including extensive evaluation of T cell receptor (TCR) repertoire, via sequencing of 2359 longitudinal samples and 180,432,350 T cells. Multimodal T cell analysis revealed that PT-Cy was associated with pan–T cell deletion followed by delayed T cell expansion from a smaller founder population compared with Tac/MTX. This created a T cell diversity bottleneck, leading to reduced TCR repertoire diversity for 2 years posttransplant. Reduced TCR diversity, more common in patients receiving PT-Cy, was linked to protection against chronic GVHD when patients were analyzed without regard to study arm. Leveraging donor- and host-specific TCR clonal analysis, we determined that PT-Cy–mediated T cell depletion also depleted pathogen-specific TCRs, rendering PT-Cy patients more likely to lack detectable graft-derived pathogen-specific TCRs early after transplant, which was associated with an increased risk of severe infection. This study reveals how distinct immunosuppression strategies uniquely remodel T cell immunity and shape divergent transplant outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Graft vs Host DiseaseHematopoietic Stem Cell TransplantationT-LymphocytesImmune ReconstitutionHumansReceptors, Antigen, T-CellCyclophosphamideFemaleMethotrexateTacrolimus

Substanzen

Receptors, Antigen, T-CellCyclophosphamideMethotrexateTacrolimus

Autor:innen und Institutionen

  • Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Department of Pediatrics, Harvard Medical School and Divisions of Infectious Diseases and Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA.
  • Adaptive Biotechnologies, Seattle, WA, USA.
  • Department of Medicine, Medical College of Wisconsin and Center for International Blood and Marrow Transplant Research (CIBMTR), Milwaukee, WI, USA.
  • Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA.
  • Harvard Medical School, Boston, MA, USA.

ORCID-Profile: Susan DeWolf, Wael Saber, Alexandre Albanese, Jiayi Dong, Michael J Martens, Brent Logan, Lorenzo Iovino, Edward Chen, James Kaminski, Donna Neuberg, Isabella Schichter, Lorenzo Cagnin, Makya Warren, Merav Bar, Saurabh Chhabra, Sung Won Choi, William Clark, Suman Das, Robert Jenq, Richard J Jones, John E Levine, Hemant Murthy, Armin Rashidi, Karamjeet Sandhu, Anthony D Sung, Mahasweta Gooptu, Hany Elmariah, Brian Shaffer, Alison W Loren, Danielle Scheffey, Mehdi Hamadani, Jarrod A Dudakov, Stephanie Bien, Harlan Robins, Shernan Holtan, Ami S Bhatt, Miguel-Angel Perales, Leslie S Kean

Förderung

  • National Institutes of Health
  • DKMS

Zitieren

APA

DeWolf, S., Siegel, S. J., Schmalz, J., Saber, W., Albanese, A., Dong, J., Martens, M. J., Logan, B., Iovino, L., Ingersoll-Ohmdahl, K., Winn, N., Chen, E., Kaminski, J., Neuberg, D., Hebert, K., Keskula, P., Zavistaski, J., Steinberg, L., Schichter, I., …, & Kean, L. S. (2026). Graft-versus-host disease prophylaxis shapes T cell biology and immune reconstitution after hematopoietic cell transplant. Science Translational Medicine. https://doi.org/10.1126/scitranslmed.aef7406

Vancouver

DeWolf S, Siegel SJ, Schmalz J, Saber W, Albanese A, Dong J, et al. Graft-versus-host disease prophylaxis shapes T cell biology and immune reconstitution after hematopoietic cell transplant. Science Translational Medicine. 2026. doi:10.1126/scitranslmed.aef7406

BibTeX
@article{DeWolf2026,
  author = {DeWolf, Susan and Siegel, Steven J and Schmalz, Joseph and Saber, Wael and Albanese, Alexandre and Dong, Jiayi and Martens, Michael J and Logan, Brent and Iovino, Lorenzo and Ingersoll-Ohmdahl, Kayleigh and Winn, Nicholas and Chen, Edward and Kaminski, James and Neuberg, Donna and Hebert, Kyle and Keskula, Paula and Zavistaski, Jillian and Steinberg, Lea and Schichter, Isabella and Katsamakis, Zoe and Cagnin, Lorenzo and Hernandez, Vanessa and Warren, Makya and Applegate, Kristy and Bar, Merav and Chhabra, Saurabh and Choi, Sung Won and Clark, William and Das, Suman and Jenq, Robert and Jones, Richard J and Levine, John E and Murthy, Hemant and Rashidi, Armin and Riches, Marcie and Sandhu, Karamjeet and Sung, Anthony D and Larkin, Karilyn and Al Malki, Monzr M and Gooptu, Mahasweta and Elmariah, Hany and Alousi, Amin and Runaas, Lyndsey and Shaffer, Brian and Rezvani, Andrew and El Jurdi, Najla and Loren, Alison W and Scheffey, Danielle and Sanders, Catherine and Hamadani, Mehdi and Dudakov, Jarrod A and Bien, Stephanie and Robins, Harlan and Horowitz, Mary and Bolaños-Meade, Javier and Holtan, Shernan and Bhatt, Ami S and Perales, Miguel-Angel and Kean, Leslie S},
  title = {Graft-versus-host disease prophylaxis shapes T cell biology and immune reconstitution after hematopoietic cell transplant},
  journal = {Science Translational Medicine},
  year = {2026},
  doi = {10.1126/scitranslmed.aef7406}
}
Kostenlos starten →